Morgan Stanley raised the firm's price target on Sonida Senior Living to $38 from $31 and keeps an Equal Weight rating on the shares. The firm updates its estimates as the CHP merger impact comes into focus, but takes "a wait and see approach on execution," the analyst tells investors.
